Kiniksa Pharmaceuticals International Plc (KNSA)
48.82
+0.69
(+1.43%)
USD |
NASDAQ |
Apr 02, 16:00
48.78
-0.04
(-0.08%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Market Cap : 3.787B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovoCure Ltd. | 1.167B |
| LivaNova Plc | 3.444B |
| Aurinia Pharmaceuticals, Inc. | 2.092B |
| Marker Therapeutics, Inc. | 21.67M |
| Alterola Biotech, Inc. | 7.444M |
Market Cap Related Metrics
| PE Ratio | 65.50 |
| PS Ratio | 5.686 |
| Price to Book Value | 6.583 |
| Price to Free Cash Flow | 28.24 |
| Price | 48.82 |
| Earnings Yield | 1.53% |
| Operating PE Ratio | 49.90 |
| Normalized PE Ratio | 65.50 |